Healthcare Sector Stocks
The Healthcare sector has a total of 1057 stocks, with a combined market cap of $8.41 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 41.77.
Market Cap
8.41T
Revenue
4.59T
Profits
201.26B
PE Ratio
41.77
Profit Margin
4.39%
Dividend Yield
0.43%
1058 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 991.62B | -0.94% | 2,383,254 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 563.77B | -0.42% | 8,548,042 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 390.87B | -0.56% | 5,624,376 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 362.83B | -1.99% | 5,838,764 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 285.12B | 0.23% | 10,459,875 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 279.89B | -0.46% | 1,868,663 | 60.44B |
| 7 | NVS | Novartis AG | 279.26B | -0.03% | 1,664,884 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 196.15B | -0.07% | 9,862,778 | 50.57B |
| 9 | AMGN | Amgen Inc. | 184.40B | -1.78% | 3,470,312 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 171.57B | -2.31% | 2,042,635 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 155.75B | -1.40% | 7,726,715 | 29.74B |
| 12 | ABT | Abbott Laboratories | 154.15B | -2.34% | 13,052,999 | 45.13B |
| 13 | PFE | Pfizer Inc. | 147.73B | -0.46% | 31,117,475 | 63.32B |
| 14 | ISRG | Intuitive Surgical, Inc. | 142.44B | -3.57% | 2,239,369 | 10.58B |
| 15 | CVS | CVS Health Corporation | 126.52B | -1.55% | 6,078,260 | 405.62B |
| 16 | DHR | Danaher Corporation | 125.81B | -1.98% | 2,692,314 | 24.78B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 116.49B | 1.28% | 1,524,291 | 12.22B |
| 18 | SYK | Stryker Corporation | 115.45B | -3.04% | 2,930,431 | 25.27B |
| 19 | BMY | Bristol-Myers Squibb Company | 112.89B | -1.14% | 8,968,567 | 48.48B |
| 20 | GSK | GSK plc | 105.47B | -0.13% | 4,016,836 | 43.29B |
| 21 | SNY | Sanofi | 104.18B | -3.52% | 8,394,357 | 54.60B |
| 22 | MDT | Medtronic plc | 100.32B | -3.91% | 11,874,714 | 36.36B |
| 23 | MCK | McKesson Corporation | 91.30B | -0.72% | 1,078,967 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 86.11B | -2.21% | 1,462,342 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 84.97B | -1.64% | 1,288,232 | 200.42B |
| 26 | CI | The Cigna Group | 75.42B | -2.33% | 1,047,636 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 66.81B | -4.20% | 20,824,302 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 61.85B | -1.11% | 1,299,691 | 14.92B |
| 29 | ARGX | argenx SE | 56.24B | 1.57% | 259,526 | 4.74B |
| 30 | COR | Cencora, Inc. | 53.91B | -1.55% | 1,466,268 | 328.68B |
| 31 | CAH | Cardinal Health, Inc. | 53.00B | -0.63% | 2,249,233 | 250.74B |
| 32 | EW | Edwards Lifesciences Corporation | 49.91B | -2.14% | 5,030,157 | 6.30B |
| 33 | TAK | Takeda Pharmaceutical Company Limited | 49.66B | -1.53% | 2,503,540 | 28.34B |
| 34 | MDLN | Medline Inc. | 47.84B | -1.81% | 10,830,345 | 29.14B |
| 35 | HUM | Humana Inc. | 43.46B | -2.03% | 1,420,293 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 43.08B | -4.70% | 619,465 | 4.45B |
| 37 | HLN | Haleon plc | 39.71B | -2.42% | 13,513,956 | 14.85B |
| 38 | BDX | Becton, Dickinson and Company | 39.02B | -2.45% | 2,921,247 | 22.23B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 37.91B | -1.06% | 5,539,753 | 17.35B |
| 40 | ALNY | Alnylam Pharmaceuticals, Inc. | 37.75B | 0.29% | 1,322,217 | 4.29B |
| 41 | A | Agilent Technologies, Inc. | 35.11B | -3.12% | 2,470,663 | 7.23B |
| 42 | WAT | Waters Corporation | 35.05B | -0.98% | 978,786 | 3.77B |
| 43 | RVMD | Revolution Medicines, Inc. | 33.54B | 0.76% | 2,227,787 | - |
| 44 | NTRA | Natera, Inc. | 32.43B | 2.88% | 1,777,619 | 2.50B |
| 45 | ZTS | Zoetis Inc. | 32.39B | -2.61% | 5,247,110 | 9.53B |
| 46 | ALC | Alcon Inc. | 32.31B | -2.58% | 3,026,040 | 10.63B |
| 47 | RPRX | Royalty Pharma plc | 30.92B | -0.94% | 3,145,669 | 2.44B |
| 48 | CNC | Centene Corporation | 29.94B | -1.22% | 5,710,757 | 178.33B |
| 49 | BIIB | Biogen Inc. | 29.33B | 1.56% | 1,009,032 | 9.94B |
| 50 | ONC | BeOne Medicines AG | 29.20B | -0.47% | 364,260 | 5.70B |
| 51 | IQV | IQVIA Holdings Inc. | 28.48B | -4.74% | 1,859,388 | 16.63B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 27.82B | -3.29% | 5,053,789 | 20.98B |
| 53 | DXCM | DexCom, Inc. | 27.49B | -2.64% | 4,431,178 | 4.82B |
| 54 | RMD | ResMed Inc. | 26.90B | -3.94% | 1,873,182 | 5.54B |
| 55 | PHG | Koninklijke Philips N.V. | 25.55B | -2.09% | 1,579,200 | 20.34B |
| 56 | VEEV | Veeva Systems Inc. | 25.15B | -5.22% | 2,247,461 | 3.32B |
| 57 | MRNA | Moderna, Inc. | 24.52B | 11.55% | 12,447,970 | 2.23B |
| 58 | ILMN | Illumina, Inc. | 24.07B | -3.16% | 1,592,688 | 4.39B |
| 59 | UTHR | United Therapeutics Corporation | 23.41B | 0.58% | 360,277 | 3.17B |
| 60 | BNTX | BioNTech SE | 23.32B | 3.04% | 902,500 | 3.23B |
| 61 | WST | West Pharmaceutical Services, Inc. | 22.86B | -1.82% | 670,339 | 3.22B |
| 62 | MTD | Mettler-Toledo International Inc. | 22.83B | -1.91% | 148,621 | 4.09B |
| 63 | ROIV | Roivant Sciences Ltd. | 22.44B | 2.60% | 7,849,172 | 8.26M |
| 64 | DGX | Quest Diagnostics Incorporated | 21.89B | -1.63% | 754,169 | 11.28B |
| 65 | INSM | Insmed Incorporated | 21.34B | 3.07% | 3,472,922 | 819.56M |
| 66 | LH | Labcorp Holdings Inc. | 21.28B | -1.96% | 544,047 | 14.14B |
| 67 | INCY | Incyte Corporation | 19.78B | -0.76% | 1,716,060 | 5.36B |
| 68 | STE | STERIS plc | 19.43B | -3.44% | 1,132,487 | 5.94B |
| 69 | VTRS | Viatris Inc. | 18.32B | -1.93% | 9,687,002 | 14.56B |
| 70 | GH | Guardant Health, Inc. | 17.12B | 1.39% | 2,118,855 | 1.08B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 16.86B | -2.43% | 1,846,195 | 8.41B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 15.99B | 1.65% | 1,037,812 | 3.10B |
| 73 | GMAB | Genmab A/S | 15.60B | 2.63% | 2,438,824 | 3.90B |
| 74 | THC | Tenet Healthcare Corporation | 15.38B | -2.76% | 1,205,695 | 21.46B |
| 75 | ASND | Ascendis Pharma A/S | 14.36B | -0.02% | 726,647 | 998.25M |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 14.24B | 0.02% | 680,038 | 4.44B |
| 77 | DVA | DaVita Inc. | 13.52B | 0.77% | 637,785 | 13.84B |
| 78 | BTSG | BrightSpring Health Services, Inc. | 13.42B | 0.45% | 2,259,816 | 13.65B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 13.20B | 1.13% | 1,601,502 | 579.96M |
| 80 | EXEL | Exelixis, Inc. | 13.18B | 0.65% | 2,016,149 | 2.38B |
| 81 | MEDP | Medpace Holdings, Inc. | 13.05B | -0.98% | 240,061 | 2.68B |
| 82 | AXSM | Axsome Therapeutics, Inc. | 12.98B | 0.10% | 519,447 | 708.24M |
| 83 | SOLV | Solventum Corporation | 12.91B | -2.61% | 1,433,720 | 8.26B |
| 84 | FMS | Fresenius Medical Care AG | 12.88B | -0.76% | 619,677 | 22.32B |
| 85 | SNN | Smith & Nephew plc | 12.85B | -1.41% | 1,715,253 | 6.16B |
| 86 | COO | The Cooper Companies, Inc. | 12.69B | -3.41% | 3,977,306 | 4.23B |
| 87 | PEN | Penumbra, Inc. | 12.44B | -0.72% | 384,665 | 1.45B |
| 88 | ALGN | Align Technology, Inc. | 12.43B | -3.34% | 843,703 | 4.10B |
| 89 | IONS | Ionis Pharmaceuticals, Inc. | 12.28B | 1.67% | 1,788,352 | 1.06B |
| 90 | ELAN | Elanco Animal Health Incorporated | 11.68B | -3.47% | 6,540,813 | 4.89B |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.52B | -0.27% | 273,216 | 1.13B |
| 92 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.42B | 5.87% | 3,099,969 | 622.01M |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 11.19B | -1.13% | 2,891,577 | 3.58B |
| 94 | ICLR | ICON Public Limited Company | 10.97B | -0.19% | 989,822 | 8.25B |
| 95 | SMMT | Summit Therapeutics Inc. | 10.92B | 1.37% | 5,961,601 | - |
| 96 | RVTY | Revvity, Inc. | 10.91B | -3.36% | 858,932 | 2.90B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.63B | -0.18% | 1,739,045 | 3.24B |
| 98 | CYTK | Cytokinetics, Incorporated | 10.61B | 3.86% | 3,340,446 | 105.82M |
| 99 | GMED | Globus Medical, Inc. | 10.24B | -2.71% | 1,441,837 | 3.10B |
| 100 | MOH | Molina Healthcare, Inc. | 10.19B | -2.34% | 866,696 | 43.10B |
| 101 | KRYS | Krystal Biotech, Inc. | 10.07B | 5.66% | 514,696 | 417.30M |
| 102 | BAX | Baxter International Inc. | 10.01B | -5.23% | 7,123,600 | 11.32B |
| 103 | PODD | Insulet Corporation | 9.94B | -2.82% | 1,542,222 | 2.90B |
| 104 | NUVL | Nuvalent, Inc. | 9.75B | -0.02% | 4,844,336 | - |
| 105 | EHC | Encompass Health Corporation | 9.71B | -1.95% | 836,269 | 6.07B |
| 106 | HSIC | Henry Schein, Inc. | 9.11B | -1.53% | 954,929 | 13.38B |
| 107 | ENSG | The Ensign Group, Inc. | 9.03B | -0.69% | 1,088,443 | 5.27B |
| 108 | CRL | Charles River Laboratories International, Inc. | 8.78B | -1.33% | 1,025,152 | 4.03B |
| 109 | CORT | Corcept Therapeutics Incorporated | 8.78B | -2.34% | 850,651 | 769.10M |
| 110 | TEM | Tempus AI, Inc. | 8.76B | -3.50% | 6,055,918 | 1.36B |
| 111 | TECH | Bio-Techne Corporation | 8.61B | -1.84% | 2,347,234 | 1.21B |
| 112 | UHS | Universal Health Services, Inc. | 8.55B | -3.84% | 857,477 | 17.76B |
| 113 | OSCR | Oscar Health, Inc. | 8.51B | -1.02% | 5,062,536 | 13.30B |
| 114 | BRKR | Bruker Corporation | 8.33B | -1.92% | 1,774,970 | 3.46B |
| 115 | ABVX | ABIVAX Société Anonyme | 8.16B | 2.72% | 1,731,309 | 5.67M |
| 116 | HALO | Halozyme Therapeutics, Inc. | 8.13B | -1.54% | 1,566,624 | 1.51B |
| 117 | ATR | AptarGroup, Inc. | 7.66B | -0.55% | 680,549 | 3.87B |
| 118 | BIO | Bio-Rad Laboratories, Inc. | 7.62B | -1.82% | 206,955 | 2.59B |
| 119 | SYRE | Spyre Therapeutics, Inc. | 7.60B | 4.89% | 1,537,190 | - |
| 120 | QGEN | Qiagen N.V. | 7.56B | -1.72% | 2,823,884 | 2.10B |
| 121 | RGEN | Repligen Corporation | 7.53B | 1.41% | 1,352,544 | 763.34M |
| 122 | PRAX | Praxis Precision Medicines, Inc. | 7.53B | 4.96% | 473,607 | 7.46M |
| 123 | GKOS | Glaukos Corporation | 7.48B | -0.09% | 1,040,931 | 551.35M |
| 124 | ALKS | Alkermes plc | 7.42B | 0.95% | 1,417,828 | 1.56B |
| 125 | KYMR | Kymera Therapeutics, Inc. | 7.39B | 2.81% | 1,092,512 | 51.48M |
| 126 | HIMS | Hims & Hers Health, Inc. | 7.38B | 1.33% | 23,154,113 | 2.37B |
| 127 | RGC | Regencell Bioscience Holdings Limited | 7.34B | -11.42% | 198,315 | - |
| 128 | IBRX | ImmunityBio, Inc. | 7.32B | 4.02% | 13,199,303 | 140.98M |
| 129 | PCVX | Vaxcyte, Inc. | 7.32B | 2.76% | 1,117,557 | - |
| 130 | TGTX | TG Therapeutics, Inc. | 7.30B | 1.90% | 3,616,109 | 700.35M |
| 131 | HQY | HealthEquity, Inc. | 7.22B | 0.78% | 1,070,985 | 1.34B |
| 132 | PTGX | Protagonist Therapeutics, Inc. | 7.17B | 0.72% | 742,535 | 74.06M |
| 133 | IMVT | Immunovant, Inc. | 7.13B | 3.27% | 1,770,159 | - |
| 134 | LNTH | Lantheus Holdings, Inc. | 6.72B | -1.75% | 933,385 | 1.55B |
| 135 | APGE | Apogee Therapeutics, Inc. | 6.63B | 3.74% | 1,223,821 | - |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.57B | 6.81% | 1,741,357 | 217.17M |
| 137 | PTCT | PTC Therapeutics, Inc. | 6.51B | 7.18% | 3,183,591 | 827.11M |
| 138 | AVTR | Avantor, Inc. | 6.46B | -1.15% | 7,909,651 | 6.55B |
| 139 | GRFS | Grifols, S.A. | 6.38B | -1.71% | 625,557 | 8.58B |
| 140 | LEGN | Legend Biotech Corporation | 6.23B | 0.42% | 1,058,200 | 1.14B |
| 141 | MIRM | Mirum Pharmaceuticals, Inc. | 6.22B | 0.48% | 1,966,068 | 569.61M |
| 142 | CNTA | Centessa Pharmaceuticals plc | 6.17B | 0.30% | 2,943,860 | 15.00M |
| 143 | LQDA | Liquidia Corporation | 6.10B | 0.94% | 1,710,641 | 288.07M |
| 144 | BLTE | Belite Bio, Inc | 5.84B | 7.34% | 332,999 | - |
| 145 | CHE | Chemed Corporation | 5.76B | 0.50% | 266,751 | 2.54B |
| 146 | COGT | Cogent Biosciences, Inc. | 5.75B | 1.81% | 2,067,975 | - |
| 147 | SRRK | Scholar Rock Holding Corporation | 5.63B | 3.05% | 1,190,135 | - |
| 148 | PACS | PACS Group, Inc. | 5.58B | -1.81% | 610,746 | 5.43B |
| 149 | TFX | Teleflex Incorporated | 5.53B | -2.28% | 427,111 | 2.13B |
| 150 | CGON | CG Oncology, Inc. | 5.33B | 0.25% | 873,600 | 5.07M |
| 151 | BLCO | Bausch + Lomb Corporation | 5.30B | -0.87% | 666,963 | 5.21B |
| 152 | LGND | Ligand Pharmaceuticals Incorporated | 5.27B | 3.09% | 354,977 | 274.48M |
| 153 | AMRX | Amneal Pharmaceuticals, Inc. | 5.19B | 0.18% | 1,572,708 | 3.05B |
| 154 | HNGE | Hinge Health, Inc. | 5.19B | -1.14% | 1,498,868 | 646.34M |
| 155 | TWST | Twist Bioscience Corporation | 5.16B | -2.45% | 1,823,721 | 409.48M |
| 156 | XENE | Xenon Pharmaceuticals Inc. | 5.14B | 2.33% | 1,155,327 | 7.50M |
| 157 | CRSP | CRISPR Therapeutics AG | 5.12B | 2.06% | 2,097,505 | 4.10M |
| 158 | CAI | Caris Life Sciences, Inc. | 5.05B | -0.67% | 2,349,846 | 907.29M |
| 159 | TVTX | Travere Therapeutics, Inc. | 5.03B | 1.42% | 1,348,024 | 536.20M |
| 160 | TNGX | Tango Therapeutics, Inc. | 4.67B | 0.40% | 2,819,406 | 56.99M |
| 161 | STVN | Stevanato Group S.p.A. | 4.66B | 3.33% | 492,569 | 1.39B |
| 162 | BLLN | BillionToOne, Inc. | 4.57B | -1.31% | 963,980 | 354.54M |
| 163 | DNTH | Dianthus Therapeutics, Inc. | 4.48B | 3.82% | 870,342 | 1.34M |
| 164 | ALHC | Alignment Healthcare, Inc. | 4.43B | 3.98% | 4,048,056 | 4.26B |
| 165 | SHC | Sotera Health Company | 4.41B | -3.62% | 3,031,896 | 1.19B |
| 166 | ERAS | Erasca, Inc. | 4.35B | 4.48% | 4,491,248 | - |
| 167 | LIVN | LivaNova PLC | 4.31B | -1.23% | 626,527 | 1.43B |
| 168 | CELC | Celcuity Inc. | 4.29B | 0.84% | 1,212,278 | - |
| 169 | ORKA | Oruka Therapeutics, Inc. | 4.27B | 4.68% | 769,911 | - |
| 170 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.17B | 3.65% | 644,958 | 754.05M |
| 171 | RDNT | RadNet, Inc. | 4.15B | -6.53% | 1,510,607 | 2.14B |
| 172 | VCYT | Veracyte, Inc. | 4.09B | 0.73% | 1,229,330 | 541.74M |
| 173 | TXG | 10x Genomics, Inc. | 4.08B | 1.20% | 4,723,356 | 638.78M |
| 174 | NVST | Envista Holdings Corporation | 4.05B | 0.44% | 3,907,747 | 2.81B |
| 175 | MMED | MiniMed Group, Inc. | 3.98B | -3.61% | 561,359 | 3.10B |
| 176 | MMSI | Merit Medical Systems, Inc. | 3.89B | -3.61% | 840,940 | 1.54B |
| 177 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | 0.16% | 2,868,493 | 596.96M |
| 178 | MANE | Veradermics, Incorporated | 3.84B | 1.01% | 415,290 | - |
| 179 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.77B | 2.14% | 743,919 | 18.07M |
| 180 | EWTX | Edgewise Therapeutics, Inc. | 3.75B | 2.56% | 3,098,789 | - |
| 181 | DOCS | Doximity, Inc. | 3.74B | -2.11% | 2,383,503 | 644.86M |
| 182 | DNLI | Denali Therapeutics Inc. | 3.73B | 7.11% | 2,605,206 | - |
| 183 | ACAD | ACADIA Pharmaceuticals Inc. | 3.70B | 3.15% | 1,340,345 | 1.10B |
| 184 | CON | Concentra Group Holdings Parent, Inc. | 3.63B | -0.28% | 801,191 | 2.23B |
| 185 | NAMS | NewAmsterdam Pharma Company N.V. | 3.52B | -0.13% | 954,298 | 22.57M |
| 186 | OGN | Organon & Co. | 3.52B | - | 2,728,947 | 6.16B |
| 187 | VKTX | Viking Therapeutics, Inc. | 3.52B | 2.16% | 1,887,679 | - |
| 188 | WAY | Waystar Holding Corp. | 3.50B | -0.71% | 4,407,340 | 1.16B |
| 189 | ICUI | ICU Medical, Inc. | 3.45B | -3.14% | 245,348 | 2.16B |
| 190 | TLX | Telix Pharmaceuticals Limited | 3.44B | 3.76% | 162,151 | 803.79M |
| 191 | OPCH | Option Care Health, Inc. | 3.41B | 0.42% | 2,436,376 | 5.67B |
| 192 | RLAY | Relay Therapeutics, Inc. | 3.39B | 3.39% | 2,863,674 | 10.68M |
| 193 | IRTC | iRhythm Holdings, Inc. | 3.35B | -6.48% | 1,244,385 | 787.85M |
| 194 | LFST | LifeStance Health Group, Inc. | 3.34B | -0.12% | 2,688,871 | 1.49B |
| 195 | PBLS | Parabilis Medicines, Inc. | 3.31B | -2.11% | 1,929,249 | - |
| 196 | HAE | Haemonetics Corporation | 3.31B | -2.28% | 1,252,738 | 1.33B |
| 197 | ARQT | Arcutis Biotherapeutics, Inc. | 3.28B | 2.14% | 1,625,102 | 415.62M |
| 198 | BKD | Brookdale Senior Living Inc. | 3.25B | -0.95% | 3,724,280 | 3.00B |
| 199 | BEAM | Beam Therapeutics Inc. | 3.23B | 4.81% | 2,174,740 | 164.01M |
| 200 | GPCR | Structure Therapeutics Inc. | 3.20B | 4.87% | 1,028,298 | - |
| 201 | DYN | Dyne Therapeutics, Inc. | 3.17B | 6.25% | 3,452,721 | - |
| 202 | ITGR | Integer Holdings Corporation | 3.04B | -1.97% | 436,184 | 1.86B |
| 203 | QURE | uniQure N.V. | 3.04B | 78.44% | 19,709,008 | 18.09M |
| 204 | RCUS | Arcus Biosciences, Inc. | 3.03B | 2.42% | 920,380 | 236.00M |
| 205 | NHC | National HealthCare Corporation | 2.98B | -0.45% | 130,170 | 1.53B |
| 206 | WRBY | Warby Parker Inc. | 2.97B | -3.62% | 3,382,655 | 890.57M |
| 207 | PRVA | Privia Health Group, Inc. | 2.95B | -0.51% | 716,408 | 2.25B |
| 208 | ALMS | Alumis Inc. | 2.94B | 3.27% | 1,423,531 | 8.40M |
| 209 | HTFL | HeartFlow, Inc. | 2.83B | 2.46% | 1,483,311 | 191.42M |
| 210 | GRDN | Guardian Pharmacy Services, Inc. | 2.75B | 2.31% | 281,643 | 1.46B |
| 211 | IDYA | IDEAYA Biosciences, Inc. | 2.75B | 2.26% | 937,775 | 225.27M |
| 212 | ELVN | Enliven Therapeutics, Inc. | 2.73B | 5.43% | 1,505,907 | - |
| 213 | TARS | Tarsus Pharmaceuticals, Inc. | 2.69B | 2.88% | 462,278 | 535.08M |
| 214 | ADPT | Adaptive Biotechnologies Corporation | 2.69B | -2.56% | 13,517,714 | 295.41M |
| 215 | IRON | Disc Medicine, Inc. | 2.68B | 0.54% | 692,514 | - |
| 216 | DFTX | Definium Therapeutics, Inc. | 2.66B | 1.12% | 1,583,193 | - |
| 217 | RARE | Ultragenyx Pharmaceutical Inc. | 2.64B | 8.29% | 3,242,964 | 670.00M |
| 218 | CLDX | Celldex Therapeutics, Inc. | 2.58B | 1.89% | 991,671 | 865.00K |
| 219 | GRAL | GRAIL, Inc. | 2.55B | 1.99% | 689,223 | 156.12M |
| 220 | TMDX | TransMedics Group, Inc. | 2.53B | -3.43% | 866,520 | 635.89M |
| 221 | SUPN | Supernus Pharmaceuticals, Inc. | 2.53B | - | 563,031 | 776.83M |
| 222 | CLOV | Clover Health Investments, Corp. | 2.53B | -2.83% | 7,264,554 | 2.21B |
| 223 | VERA | Vera Therapeutics, Inc. | 2.51B | 3.98% | 1,122,307 | - |
| 224 | KLRA | Kailera Therapeutics, Inc. | 2.48B | 3.13% | 746,879 | - |
| 225 | ESTA | Establishment Labs Holdings Inc. | 2.42B | -0.22% | 782,048 | 229.58M |
| 226 | AXGN | Axogen, Inc. | 2.37B | 2.70% | 1,800,373 | 238.11M |
| 227 | PHVS | Pharvaris N.V. | 2.33B | 6.20% | 287,421 | - |
| 228 | TRVI | Trevi Therapeutics, Inc. | 2.32B | 6.30% | 2,675,897 | - |
| 229 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.27B | 0.34% | 4,450,757 | 885.72M |
| 230 | KOD | Kodiak Sciences Inc. | 2.23B | 8.41% | 886,017 | - |
| 231 | PBH | Prestige Consumer Healthcare Inc. | 2.19B | -2.86% | 939,095 | 1.09B |
| 232 | ACHC | Acadia Healthcare Company, Inc. | 2.16B | -5.96% | 3,213,585 | 3.37B |
| 233 | NTLA | Intellia Therapeutics, Inc. | 2.12B | 4.47% | 12,427,239 | 66.09M |
| 234 | OCUL | Ocular Therapeutix, Inc. | 2.11B | 7.83% | 7,403,977 | 52.04M |
| 235 | LMAT | LeMaitre Vascular, Inc. | 2.11B | -1.26% | 257,947 | 256.28M |
| 236 | IMNM | Immunome, Inc. | 2.10B | 3.46% | 1,419,683 | 4.02M |
| 237 | AUPH | Aurinia Pharmaceuticals Inc. | 2.08B | -0.49% | 818,397 | 298.30M |
| 238 | MLYS | Mineralys Therapeutics, Inc. | 2.07B | 4.75% | 1,646,411 | - |
| 239 | NVCR | NovoCure Limited | 2.07B | 2.06% | 1,308,959 | 674.41M |
| 240 | PGNY | Progyny, Inc. | 2.06B | -1.09% | 1,178,776 | 1.29B |
| 241 | NKTR | Nektar Therapeutics | 2.06B | 1.08% | 676,732 | 55.63M |
| 242 | SEM | Select Medical Holdings Corporation | 2.05B | -0.36% | 1,117,123 | 5.52B |
| 243 | BHVN | Biohaven Ltd. | 2.05B | 12.66% | 6,982,351 | - |
| 244 | XRAY | DENTSPLY SIRONA Inc. | 2.01B | -4.02% | 5,789,281 | 3.68B |
| 245 | ZLAB | Zai Lab Limited | 2.01B | 0.85% | 1,011,607 | 453.28M |
| 246 | VCEL | Vericel Corporation | 2.00B | 1.74% | 777,644 | 292.09M |
| 247 | MBX | MBX Biosciences, Inc. | 1.98B | 3.74% | 676,980 | - |
| 248 | AGIO | Agios Pharmaceuticals, Inc. | 1.97B | 3.89% | 920,521 | 66.05M |
| 249 | HRMY | Harmony Biosciences Holdings, Inc. | 1.96B | -0.18% | 626,918 | 899.11M |
| 250 | ADMA | ADMA Biologics, Inc. | 1.95B | -1.86% | 3,223,363 | 509.86M |
| 251 | NEOG | Neogen Corporation | 1.94B | -4.08% | 1,520,276 | 870.56M |
| 252 | ASTH | Astrana Health, Inc. | 1.89B | -0.57% | 429,408 | 3.53B |
| 253 | LKFT | Lakefront Biotherapeutics NV | 1.89B | 0.67% | 125,293 | 1.20B |
| 254 | MD | Pediatrix Medical Group, Inc. | 1.89B | -2.48% | 648,292 | 1.93B |
| 255 | STOK | Stoke Therapeutics, Inc. | 1.88B | 3.81% | 955,162 | 32.08M |
| 256 | NUVB | Nuvation Bio Inc. | 1.86B | 4.10% | 5,416,904 | 143.05M |
| 257 | VRDN | Viridian Therapeutics, Inc. | 1.85B | 4.57% | 2,030,808 | 70.92M |
| 258 | SGRY | Surgery Partners, Inc. | 1.84B | -6.01% | 868,041 | 3.34B |
| 259 | TRLV | Trulieve Cannabis Corp. | 1.82B | 0.53% | 2,248,430 | 1.17B |
| 260 | MESO | Mesoblast Limited | 1.81B | 1.60% | 151,432 | 65.38M |
| 261 | HCM | HUTCHMED (China) Limited | 1.81B | -3.53% | 50,799 | 548.51M |
| 262 | NBTX | Nanobiotix S.A. | 1.80B | 0.22% | 74,207 | 38.27M |
| 263 | SRPT | Sarepta Therapeutics, Inc. | 1.79B | 7.48% | 4,512,853 | 2.18B |
| 264 | TSHA | Taysha Gene Therapies, Inc. | 1.78B | 5.81% | 2,274,394 | 7.47M |
| 265 | GENB | Generate Biomedicines, Inc. | 1.78B | 3.74% | 802,113 | 30.30M |
| 266 | BHC | Bausch Health Companies Inc. | 1.78B | -4.03% | 1,822,868 | 10.53B |
| 267 | NRIX | Nurix Therapeutics, Inc. | 1.77B | 0.29% | 2,514,281 | 71.78M |
| 268 | RAPP | Rapport Therapeutics, Inc. | 1.76B | -4.21% | 273,473 | 20.00M |
| 269 | UFPT | UFP Technologies, Inc. | 1.76B | -1.95% | 220,134 | 608.85M |
| 270 | PLSE | Pulse Biosciences, Inc. | 1.76B | 1.35% | 196,689 | 751.00K |
| 271 | IOVA | Iovance Biotherapeutics, Inc. | 1.75B | 2.88% | 11,208,026 | 285.61M |
| 272 | OMCL | Omnicell, Inc. | 1.75B | -3.51% | 618,557 | 1.23B |
| 273 | AGL | agilon health, inc. | 1.75B | -7.59% | 288,009 | 5.82B |
| 274 | TYRA | Tyra Biosciences, Inc. | 1.73B | 3.05% | 743,999 | - |
| 275 | ADUS | Addus HomeCare Corporation | 1.72B | -0.89% | 186,184 | 1.45B |
| 276 | ANIP | ANI Pharmaceuticals, Inc. | 1.71B | -2.99% | 301,556 | 923.71M |
| 277 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.70B | 1.33% | 1,090,373 | -665.00K |
| 278 | ZYME | Zymeworks Inc. | 1.69B | 2.89% | 697,677 | 81.26M |
| 279 | SNDX | Syndax Pharmaceuticals, Inc. | 1.69B | 2.64% | 1,900,539 | 217.17M |
| 280 | PGEN | Precigen, Inc. | 1.69B | -0.42% | 3,834,277 | 31.60M |
| 281 | WGS | GeneDx Holdings Corp. | 1.67B | -6.90% | 1,133,134 | 442.68M |
| 282 | INVA | Innoviva, Inc. | 1.67B | 0.13% | 588,385 | 420.69M |
| 283 | ABCL | AbCellera Biologics Inc. | 1.66B | 6.88% | 5,645,750 | 79.21M |
| 284 | SION | Sionna Therapeutics, Inc. | 1.66B | 5.70% | 406,686 | - |
| 285 | ANAB | AnaptysBio, Inc. | 1.65B | -1.46% | 603,716 | 232.39M |
| 286 | RXRX | Recursion Pharmaceuticals, Inc. | 1.65B | -2.20% | 22,173,126 | 66.41M |
| 287 | AVAH | Aveanna Healthcare Holdings Inc. | 1.64B | 0.27% | 1,708,754 | 2.52B |
| 288 | CAPR | Capricor Therapeutics, Inc. | 1.62B | 7.29% | 1,460,392 | 11.13M |
| 289 | SNDA | Sonida Senior Living, Inc. | 1.62B | -0.54% | 629,542 | 367.34M |
| 290 | PVLA | Palvella Therapeutics, Inc. | 1.62B | 2.28% | 181,858 | - |
| 291 | SEPN | Septerna, Inc. | 1.61B | 1.79% | 325,299 | 72.26M |
| 292 | CMPS | COMPASS Pathways plc | 1.61B | 3.92% | 2,079,338 | - |
| 293 | URGN | UroGen Pharma Ltd. | 1.60B | 2.69% | 547,701 | 140.49M |
| 294 | VIR | Vir Biotechnology, Inc. | 1.57B | 8.01% | 3,000,584 | 65.50M |
| 295 | HROW | Harrow, Inc. | 1.56B | 9.22% | 1,227,054 | 268.68M |
| 296 | NVAX | Novavax, Inc. | 1.56B | 3.26% | 3,901,672 | 596.34M |
| 297 | GLUE | Monte Rosa Therapeutics, Inc. | 1.56B | 3.66% | 1,184,533 | 42.95M |
| 298 | AAPG | Ascentage Pharma Group International | 1.54B | 0.47% | 15,117 | 82.08M |
| 299 | HCSG | Healthcare Services Group, Inc. | 1.54B | -0.84% | 735,809 | 1.85B |
| 300 | BCAX | Bicara Therapeutics Inc. | 1.51B | 4.42% | 609,625 | - |
| 301 | ATAI | AtaiBeckley Inc. | 1.50B | -1.69% | 3,979,038 | 3.49M |
| 302 | BFLY | Butterfly Network, Inc. | 1.49B | 1.06% | 6,517,052 | 102.92M |
| 303 | GHRS | GH Research PLC | 1.49B | 8.61% | 178,554 | - |
| 304 | AVBP | ArriVent BioPharma, Inc. | 1.46B | 3.40% | 529,077 | - |
| 305 | STAA | STAAR Surgical Company | 1.45B | 1.04% | 484,303 | 290.38M |
| 306 | IMCR | Immunocore Holdings plc | 1.45B | 1.35% | 683,075 | 412.81M |
| 307 | FTRE | Fortrea Holdings Inc. | 1.45B | -4.13% | 1,087,244 | 2.71B |
| 308 | SLS | SELLAS Life Sciences Group, Inc. | 1.44B | 3.05% | 4,681,749 | - |
| 309 | ARDX | Ardelyx, Inc. | 1.44B | 3.00% | 3,424,545 | 427.68M |
| 310 | MLTX | MoonLake Immunotherapeutics | 1.41B | 1.11% | 878,842 | - |
| 311 | PRGO | Perrigo Company plc | 1.41B | -4.78% | 3,162,204 | 4.18B |
| 312 | ALMR | Alamar Biosciences, Inc. | 1.40B | 0.70% | 253,176 | 87.16M |
| 313 | INBX | Inhibrx Biosciences, Inc. | 1.38B | 1.17% | 269,197 | 1.30M |
| 314 | MAZE | Maze Therapeutics, Inc. | 1.37B | 4.11% | 473,980 | 20.00M |
| 315 | ATRC | AtriCure, Inc. | 1.37B | -3.07% | 828,897 | 552.16M |
| 316 | TDOC | Teladoc Health, Inc. | 1.37B | 0.26% | 4,435,201 | 2.51B |
| 317 | SVRA | Savara Inc. | 1.36B | 1.51% | 1,392,920 | - |
| 318 | NEO | NeoGenomics, Inc. | 1.35B | -1.05% | 13,957,085 | 745.97M |
| 319 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.35B | 4.19% | 1,920,382 | 204.73M |
| 320 | IART | Integra LifeSciences Holdings Corporation | 1.34B | -2.88% | 791,527 | 1.64B |
| 321 | MPLT | MapLight Therapeutics, Inc. | 1.32B | 7.55% | 410,719 | - |
| 322 | DMRA | Damora Therapeutics, Inc. | 1.32B | 4.03% | 259,080 | - |
| 323 | ARDT | Ardent Health, Inc. | 1.30B | -1.94% | 342,557 | 6.43B |
| 324 | IMTX | Immatics N.V. | 1.30B | 4.73% | 292,980 | 43.00M |
| 325 | AKTS | Aktis Oncology, Inc. | 1.30B | 3.98% | 523,598 | 8.28M |
| 326 | AHCO | AdaptHealth Corp. | 1.27B | -6.02% | 2,337,719 | 3.29B |
| 327 | ATEC | Alphatec Holdings, Inc. | 1.27B | -2.37% | 5,025,930 | 787.08M |
| 328 | AMN | AMN Healthcare Services, Inc. | 1.26B | 1.57% | 1,899,372 | 3.42B |
| 329 | PAHC | Phibro Animal Health Corporation | 1.25B | -3.23% | 238,061 | 1.50B |
| 330 | BLFS | BioLife Solutions, Inc. | 1.25B | -2.96% | 872,207 | 101.66M |
| 331 | INNV | InnovAge Holding Corp. | 1.24B | -1.40% | 315,893 | 949.17M |
| 332 | AVLN | Avalyn Pharma Inc. | 1.23B | 4.42% | 543,614 | - |
| 333 | ALVO | Alvotech | 1.22B | 1.16% | 882,239 | 562.04M |
| 334 | CDNA | CareDx, Inc. | 1.21B | 0.99% | 970,634 | 412.82M |
| 335 | MNKD | MannKind Corporation | 1.21B | 1.29% | 3,665,280 | 360.78M |
| 336 | PNTG | The Pennant Group, Inc. | 1.20B | 2.07% | 487,131 | 1.02B |
| 337 | ENOV | Enovis Corporation | 1.20B | -3.38% | 1,101,770 | 2.28B |
| 338 | XERS | Xeris Biopharma Holdings, Inc. | 1.19B | - | 1,482,472 | 314.85M |
| 339 | PRCT | PROCEPT BioRobotics Corporation | 1.19B | -5.38% | 2,798,875 | 322.02M |
| 340 | INSP | Inspire Medical Systems, Inc. | 1.18B | -0.65% | 559,883 | 915.25M |
| 341 | ZBIO | Zenas BioPharma, Inc. | 1.17B | 2.14% | 602,752 | 10.00M |
| 342 | COAG | Hemab Therapeutics Holdings, Inc. | 1.17B | 3.68% | 372,565 | - |
| 343 | AVNS | Avanos Medical, Inc. | 1.16B | -0.36% | 1,580,400 | 715.90M |
| 344 | IRMD | IRADIMED CORPORATION | 1.16B | -0.82% | 121,915 | 86.28M |
| 345 | SDGR | Schrödinger, Inc. | 1.16B | 4.02% | 1,485,317 | 254.91M |
| 346 | WVE | Wave Life Sciences Ltd. | 1.14B | 3.66% | 5,190,012 | 71.80M |
| 347 | ABSI | Absci Corporation | 1.12B | 2.57% | 6,358,722 | 1.84M |
| 348 | KMTS | Kestra Medical Technologies, Ltd. | 1.11B | -0.78% | 280,256 | 83.72M |
| 349 | EYPT | EyePoint, Inc. | 1.10B | 2.10% | 1,180,462 | 7.61M |
| 350 | COLL | Collegium Pharmaceutical, Inc. | 1.09B | -2.80% | 413,792 | 796.33M |
| 351 | OPK | OPKO Health, Inc. | 1.06B | 1.44% | 2,053,532 | 581.12M |
| 352 | TNDM | Tandem Diabetes Care, Inc. | 1.06B | -7.73% | 2,102,986 | 1.03B |
| 353 | AHG | Akso Health Group | 1.05B | 1.65% | 4,125 | 14.84M |
| 354 | AZTA | Azenta, Inc. | 1.05B | -1.97% | 629,940 | 596.48M |
| 355 | SLBT | SL Science Holding Limited | 1.03B | -28.23% | 1,404,200 | - |
| 356 | AORT | Artivion, Inc. | 1.03B | -1.17% | 837,743 | 458.69M |
| 357 | OMDA | Omada Health, Inc. | 1.03B | 0.82% | 777,403 | 283.30M |
| 358 | PSNL | Personalis, Inc. | 1.02B | 0.62% | 3,261,601 | 64.52M |
| 359 | CRVS | Corvus Pharmaceuticals, Inc. | 1.01B | 2.21% | 1,171,644 | - |
| 360 | NUTX | Nutex Health Inc. | 1.01B | 1.62% | 59,429 | 879.95M |
| 361 | CRON | Cronos Group Inc. | 1.00B | 2.69% | 727,899 | 159.54M |
| 362 | JBIO | Jade Biosciences, Inc. | 1.00B | 8.63% | 738,111 | - |
| 363 | DBVT | DBV Technologies S.A. | 998.84M | -2.81% | 225,078 | 5.74M |
| 364 | SPRY | ARS Pharmaceuticals, Inc. | 983.10M | 2.06% | 1,018,637 | 98.99M |
| 365 | EVO | Evotec SE | 974.56M | -2.97% | 99,879 | 859.03M |
| 366 | CNMD | CONMED Corporation | 966.81M | -7.12% | 921,324 | 1.37B |
| 367 | MGTX | MeiraGTx Holdings plc | 964.07M | 7.21% | 1,013,899 | 79.76M |
| 368 | USPH | U.S. Physical Therapy, Inc. | 956.35M | -5.35% | 252,685 | 787.69M |
| 369 | XNCR | Xencor, Inc. | 947.53M | 4.75% | 1,051,848 | 97.36M |
| 370 | CERT | Certara, Inc. | 938.05M | -0.33% | 4,206,863 | 419.75M |
| 371 | AVR | Anteris Technologies Global Corp. | 924.75M | 2.48% | 1,163,995 | 1.85M |
| 372 | PHAR | Pharming Group N.V. | 923.03M | 1.12% | 1,839 | 369.49M |
| 373 | SPTX | Seaport Therapeutics, Inc. | 915.37M | -4.84% | 259,295 | - |
| 374 | SANA | Sana Biotechnology, Inc. | 911.69M | 7.42% | 6,254,569 | - |
| 375 | LXRX | Lexicon Pharmaceuticals, Inc. | 906.16M | 4.62% | 2,622,399 | 69.64M |
| 376 | ETON | Eton Pharmaceuticals, Inc. | 897.37M | 1.27% | 341,852 | 86.93M |
| 377 | QDEL | QuidelOrtho Corporation | 895.35M | -7.01% | 1,484,680 | 2.66B |
| 378 | ORIC | ORIC Pharmaceuticals, Inc. | 893.36M | 3.85% | 1,434,536 | - |
| 379 | PCRX | Pacira BioSciences, Inc. | 890.84M | -0.79% | 342,305 | 734.86M |
| 380 | BIOA | BioAge Labs, Inc. | 888.61M | -2.44% | 495,603 | 10.32M |
| 381 | CGEM | Cullinan Therapeutics, Inc. | 887.45M | 6.57% | 1,527,526 | - |
| 382 | GDRX | GoodRx Holdings, Inc. | 883.94M | -4.40% | 1,084,953 | 787.89M |
| 383 | ABUS | Arbutus Biopharma Corporation | 875.09M | 0.91% | 2,031,638 | 191.45M |
| 384 | PHAT | Phathom Pharmaceuticals, Inc. | 873.73M | 5.47% | 860,701 | 204.89M |
| 385 | ODTX | Odyssey Therapeutics, Inc. | 871.78M | 3.41% | 471,203 | 2.98M |
| 386 | TALK | Talkspace, Inc. | 871.07M | - | 2,856,895 | 238.37M |
| 387 | DRTS | Alpha Tau Medical Ltd. | 866.59M | 2.78% | 482,660 | - |
| 388 | JANX | Janux Therapeutics, Inc. | 862.93M | 3.28% | 1,931,846 | 13.73M |
| 389 | LBRX | LB Pharmaceuticals Inc | 861.73M | 8.64% | 334,451 | - |
| 390 | TBPH | Theravance Biopharma, Inc. | 861.45M | 0.12% | 424,380 | 109.78M |
| 391 | AMPH | Amphastar Pharmaceuticals, Inc. | 855.84M | -2.76% | 1,008,517 | 720.53M |
| 392 | KURA | Kura Oncology, Inc. | 849.57M | 1.81% | 1,804,079 | 71.64M |
| 393 | INMD | InMode Ltd. | 846.47M | -0.96% | 618,743 | 374.64M |
| 394 | LMRI | Lumexa Imaging Holdings, Inc. | 844.55M | -2.66% | 798,780 | 1.03B |
| 395 | REPL | Replimune Group, Inc. | 825.73M | 13.90% | 4,316,730 | - |
| 396 | OLMA | Olema Pharmaceuticals, Inc. | 824.56M | 2.72% | 1,733,719 | - |
| 397 | ESPR | Esperion Therapeutics, Inc. | 816.06M | 0.32% | 16,154,950 | 418.24M |
| 398 | VOR | Vor Biopharma Inc. | 813.87M | 6.45% | 1,110,362 | - |
| 399 | AVTX | Avalo Therapeutics, Inc. | 809.51M | 7.47% | 1,165,483 | 59.00K |
| 400 | ANNX | Annexon, Inc. | 809.38M | 9.29% | 2,376,527 | - |
| 401 | GERN | Geron Corporation | 789.07M | 4.24% | 13,869,370 | 196.12M |
| 402 | ANRO | Alto Neuroscience, Inc. | 764.70M | 3.76% | 272,799 | - |
| 403 | HSTM | HealthStream, Inc. | 759.59M | 0.85% | 242,723 | 311.78M |
| 404 | IVA | Inventiva S.A. | 751.19M | -1.40% | 1,033,906 | 7.94M |
| 405 | ZVRA | Zevra Therapeutics, Inc. | 745.44M | -0.32% | 1,381,972 | 122.29M |
| 406 | DSGN | Design Therapeutics, Inc. | 745.11M | 11.29% | 1,021,731 | - |
| 407 | EVMN | Evommune, Inc. | 743.78M | 2.99% | 602,898 | 10.00M |
| 408 | SLDB | Solid Biosciences Inc. | 719.67M | 3.39% | 3,405,271 | - |
| 409 | BVS | Bioventus Inc. | 713.39M | -2.06% | 366,797 | 576.30M |
| 410 | TENX | Tenax Therapeutics, Inc. | 698.89M | 4.77% | 1,280,545 | - |
| 411 | OMER | Omeros Corporation | 697.70M | 1.69% | 1,417,148 | 9.89M |
| 412 | NNNN | Anbio Biotechnology | 696.11M | -1.73% | 11,396 | 8.65M |
| 413 | AURA | Aura Biosciences, Inc. | 695.99M | 0.48% | 531,094 | - |
| 414 | RLMD | Relmada Therapeutics, Inc. | 692.28M | 0.76% | 1,358,724 | - |
| 415 | OCS | Oculis Holding AG | 682.39M | -1.31% | 581,064 | 1.40M |
| 416 | CRMD | CorMedix Inc. | 680.18M | 0.12% | 1,189,005 | 400.05M |
| 417 | ALLO | Allogene Therapeutics, Inc. | 676.50M | 3.16% | 6,362,246 | 22.00K |
| 418 | SIBN | SI-BONE, Inc. | 674.55M | -1.30% | 630,982 | 206.22M |
| 419 | SSII | SS Innovations International, Inc. | 658.43M | -5.19% | 53,994 | 48.47M |
| 420 | CBLL | CeriBell, Inc. | 655.65M | -3.57% | 402,143 | 95.07M |
| 421 | IMMX | Immix Biopharma, Inc. | 649.96M | 4.46% | 1,963,449 | - |
| 422 | CLYM | Climb Bio, Inc. | 649.33M | 5.88% | 906,917 | - |
| 423 | GMRS | GMR Solutions Inc. | 648.68M | 0.08% | 762,276 | 5.83B |
| 424 | CTMX | CytomX Therapeutics, Inc. | 644.40M | 1.02% | 5,519,809 | 35.54M |
| 425 | TRAX | First Tracks Biotherapeutics, Inc. | 633.99M | 6.01% | 734,367 | - |
| 426 | RIGL | Rigel Pharmaceuticals, Inc. | 617.41M | 2.80% | 264,172 | 299.77M |
| 427 | ACRS | Aclaris Therapeutics, Inc. | 617.31M | 1.84% | 1,187,760 | 8.37M |
| 428 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 615.22M | -0.65% | 557,272 | - |
| 429 | CSTL | Castle Biosciences, Inc. | 614.18M | -1.03% | 310,438 | 339.92M |
| 430 | SGP | SpyGlass Pharma, Inc. | 608.36M | 3.64% | 108,919 | - |
| 431 | CBIO | Crescent Biopharma, Inc. | 605.10M | 1.45% | 382,005 | 11.88M |
| 432 | DRUG | Bright Minds Biosciences Inc. | 592.58M | -0.50% | 152,610 | - |
| 433 | BBNX | Beta Bionics, Inc. | 587.77M | -5.45% | 1,230,880 | 110.24M |
| 434 | CADL | Candel Therapeutics, Inc. | 585.43M | 0.25% | 1,373,697 | - |
| 435 | TCMD | Tactile Systems Technology, Inc. | 582.63M | -2.27% | 135,269 | 343.52M |
| 436 | IRWD | Ironwood Pharmaceuticals, Inc. | 579.44M | -3.83% | 1,629,223 | 361.51M |
| 437 | BWAY | BrainsWay Ltd. | 578.01M | 1.98% | 78,984 | 56.22M |
| 438 | PHR | Phreesia, Inc. | 577.94M | -0.95% | 1,415,531 | 495.59M |
| 439 | PRME | Prime Medicine, Inc. | 570.75M | 10.10% | 4,211,334 | 4.03M |
| 440 | TECX | Tectonic Therapeutic, Inc. | 567.21M | 0.17% | 190,391 | - |
| 441 | TLRY | Tilray Brands, Inc. | 566.59M | -2.66% | 4,106,640 | 858.28M |
| 442 | DNA | Ginkgo Bioworks Holdings, Inc. | 558.52M | 4.14% | 1,176,248 | 151.40M |
| 443 | AQST | Aquestive Therapeutics, Inc. | 555.74M | 3.99% | 1,977,232 | 50.27M |
| 444 | GYRE | Gyre Therapeutics, Inc. | 555.54M | 4.47% | 66,354 | 117.05M |
| 445 | ACHV | Achieve Life Sciences, Inc. | 550.25M | -3.42% | 1,664,883 | - |
| 446 | MDXG | MiMedx Group, Inc. | 537.69M | -2.43% | 998,781 | 389.42M |
| 447 | PROK | ProKidney Corp. | 528.60M | 3.55% | 755,692 | 889.00K |
| 448 | EIKN | Eikon Therapeutics, Inc. | 526.77M | 7.28% | 265,706 | - |
| 449 | EVH | Evolent Health, Inc. | 525.29M | -0.64% | 1,912,021 | 1.89B |
| 450 | TOI | The Oncology Institute, Inc. | 524.91M | 2.94% | 1,979,483 | 545.76M |
| 451 | XOMA | XOMA Royalty Corporation | 523.21M | -0.14% | 80,470 | 48.56M |
| 452 | NPCE | NeuroPace, Inc. | 516.86M | 0.93% | 162,568 | 99.53M |
| 453 | CERS | Cerus Corporation | 514.95M | 4.05% | 2,530,730 | 216.56M |
| 454 | CTKB | Cytek Biosciences, Inc. | 513.99M | -2.69% | 2,032,607 | 204.17M |
| 455 | ALT | Altimmune, Inc. | 513.41M | 0.76% | 3,570,898 | 36.00K |
| 456 | VALN | Valneva SE | 511.98M | -0.19% | 10,426 | 180.25M |
| 457 | INDP | Indaptus Therapeutics, Inc. | 509.59M | 20.97% | 749,137 | - |
| 458 | CTEV | Claritev Corporation | 507.17M | -3.00% | 95,710 | 978.76M |
| 459 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 5.42M |
| 460 | CLPT | ClearPoint Neuro, Inc. | 504.12M | 26.01% | 6,884,433 | 40.61M |
| 461 | FLGT | Fulgent Genetics, Inc. | 502.69M | -1.61% | 274,739 | 320.35M |
| 462 | SRTA | Strata Critical Medical, Inc. | 500.99M | -0.86% | 1,657,769 | 228.58M |
| 463 | RZLT | Rezolute, Inc. | 500.40M | 4.81% | 3,081,730 | - |
| 464 | AGMB | AgomAb Therapeutics NV | 497.40M | 1.00% | 116,748 | - |
| 465 | ARVN | Arvinas, Inc. | 494.88M | 3.37% | 638,617 | 89.40M |
| 466 | FDMT | 4D Molecular Therapeutics, Inc. | 492.44M | 8.65% | 962,824 | 88.24M |
| 467 | ANGO | AngioDynamics, Inc. | 489.35M | -3.37% | 377,798 | 313.73M |
| 468 | KYTX | Kyverna Therapeutics, Inc. | 486.66M | 1.52% | 811,543 | - |
| 469 | NGNE | Neurogene Inc. | 486.54M | 4.91% | 250,998 | 925.00K |
| 470 | ARTV | Artiva Biotherapeutics, Inc. | 482.97M | 11.56% | 952,270 | 251.00K |
| 471 | MOBI | Mobia Medical, Inc. | 480.73M | 9.74% | 263,792 | 32.04M |
| 472 | ASMB | Assembly Biosciences, Inc. | 478.59M | 3.51% | 133,828 | 71.10M |
| 473 | STRO | Sutro Biopharma, Inc. | 470.77M | 0.85% | 499,888 | 99.61M |
| 474 | KIDS | OrthoPediatrics Corp. | 466.70M | -1.94% | 144,631 | 243.30M |
| 475 | CABA | Cabaletta Bio, Inc. | 463.08M | 1.43% | 5,139,474 | - |
| 476 | CTNM | Contineum Therapeutics, Inc. | 454.62M | -1.94% | 200,884 | - |
| 477 | OVID | Ovid Therapeutics Inc. | 451.67M | 2.54% | 3,863,517 | 7.12M |
| 478 | PRTA | Prothena Corporation plc | 444.48M | 2.41% | 542,968 | 57.94M |
| 479 | EOLS | Evolus, Inc. | 443.86M | 1.66% | 1,040,108 | 301.79M |
| 480 | CCCC | C4 Therapeutics, Inc. | 433.42M | 2.08% | 2,094,680 | 34.86M |
| 481 | PRLD | Prelude Therapeutics Incorporated | 431.42M | 3.57% | 317,740 | 16.72M |
| 482 | MNPR | Monopar Therapeutics Inc. | 431.33M | 3.27% | 122,971 | - |
| 483 | VREX | Varex Imaging Corporation | 429.89M | -2.86% | 247,101 | 857.50M |
| 484 | FBRX | Forte Biosciences, Inc. | 429.82M | 2.57% | 156,129 | - |
| 485 | KMDA | Kamada Ltd. | 425.65M | -2.68% | 21,701 | 181.68M |
| 486 | VTVT | vTv Therapeutics Inc. | 420.93M | 5.21% | 78,192 | 36.84M |
| 487 | WEAV | Weave Communications, Inc. | 420.90M | -3.29% | 856,792 | 248.72M |
| 488 | EBS | Emergent BioSolutions Inc. | 419.99M | 5.03% | 990,619 | 676.80M |
| 489 | OCGN | Ocugen, Inc. | 416.38M | 4.24% | 6,326,911 | 4.47M |
| 490 | PACB | Pacific Biosciences of California, Inc. | 416.21M | -0.74% | 4,798,087 | 160.03M |
| 491 | MYGN | Myriad Genetics, Inc. | 413.68M | 3.06% | 876,792 | 829.00M |
| 492 | DCTH | Delcath Systems, Inc. | 411.84M | 3.38% | 727,075 | 90.44M |
| 493 | EPRX | Eupraxia Pharmaceuticals Inc. | 410.73M | 4.31% | 435,302 | - |
| 494 | ANL | Adlai Nortye Ltd. | 410.40M | 2.09% | 82,335 | 5.00M |
| 495 | RGNX | REGENXBIO Inc. | 408.41M | 14.00% | 4,964,676 | 87.82M |
| 496 | CCRN | Cross Country Healthcare, Inc. | 408.38M | -0.08% | 861,655 | 1.00B |
| 497 | AUTL | Autolus Therapeutics plc | 407.20M | 2.68% | 999,279 | 92.62M |
| 498 | CYH | Community Health Systems, Inc. | 406.36M | -4.46% | 1,062,565 | 12.29B |
| 499 | IPSC | Century Therapeutics, Inc. | 405.80M | 3.21% | 959,727 | 109.16M |
| 500 | BNTC | Benitec Biopharma Inc. | 405.38M | 6.31% | 152,198 | - |